|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP |
Ethidium inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] |
CTD |
PMID:15897899 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions |
EXP |
Ethidium inhibits the reaction [Estradiol results in increased expression of CCND1 mRNA] |
CTD |
PMID:15897899 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCNE1 |
cyclin E1 |
multiple interactions |
EXP |
Ethidium inhibits the reaction [Estradiol results in increased expression of CCNE1 mRNA] |
CTD |
PMID:15897899 |
|
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
|
|
G |
CCNE2 |
cyclin E2 |
multiple interactions |
EXP |
Ethidium inhibits the reaction [Estradiol results in increased expression of CCNE2 mRNA] |
CTD |
PMID:15897899 |
|
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
|
|
G |
CD59 |
CD59 molecule (CD59 blood group) |
increases mutagenesis |
EXP |
Ethidium results in increased mutagenesis of CD59 protein |
CTD |
PMID:17045307 |
|
NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
|
|
G |
ERO1A |
endoplasmic reticulum oxidoreductase 1 alpha |
multiple interactions |
ISO |
[Pyruvic Acid co-treated with Uridine co-treated with Ethidium] inhibits the reaction [Rotenone inhibits the reaction [arsenite results in increased expression of ERO1A protein]] |
CTD |
PMID:37659621 |
|
NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,695,900
|
|
G |
GJA1 |
gap junction protein alpha 1 |
increases uptake |
ISO |
GJA1 protein results in increased uptake of Ethidium |
CTD |
PMID:26926986 |
|
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
|
|
G |
IL1A |
interleukin 1 alpha |
multiple interactions |
ISO |
Ethidium inhibits the reaction [sodium arsenate results in increased expression of IL1A protein]; Ethidium inhibits the reaction [tributyltin results in increased expression of IL1A protein] |
CTD |
PMID:8875956 PMID:10571731 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
MT-CO1 |
mitochondrially encoded cytochrome c oxidase I |
decreases expression |
EXP |
Ethidium results in decreased expression of COX1 protein |
CTD |
PMID:18823003 |
|
NCBI chr MT:5,904...7,445
Ensembl chr MT:5,904...7,445
|
|
G |
MT-CO2 |
mitochondrially encoded cytochrome c oxidase II |
decreases expression |
EXP |
Ethidium results in decreased expression of COX2 mRNA |
CTD |
PMID:22712077 |
|
NCBI chr MT:7,586...8,269
Ensembl chr MT:7,586...8,269
|
|
G |
MT-CYB |
mitochondrially encoded cytochrome b |
decreases expression |
EXP |
Ethidium results in decreased expression of CYTB mRNA |
CTD |
PMID:22712077 |
|
NCBI chr MT:14,747...15,887
Ensembl chr MT:14,747...15,887
|
|
G |
MT-ND1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
decreases expression |
EXP |
Ethidium results in decreased expression of ND1 mRNA |
CTD |
PMID:22712077 |
|
NCBI chr MT:3,307...4,262
Ensembl chr MT:3,307...4,262
|
|
G |
MT-ND4 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 |
decreases expression |
EXP |
Ethidium results in decreased expression of ND4 mRNA |
CTD |
PMID:22712077 |
|
NCBI chr MT:10,760...12,137
Ensembl chr MT:10,760...12,137
|
|
G |
NRF1 |
nuclear respiratory factor 1 |
increases expression |
EXP |
Ethidium results in increased expression of NRF1 mRNA |
CTD |
PMID:22712077 |
|
NCBI chr 7:129,611,720...129,757,076
Ensembl chr 7:129,611,720...129,757,082
|
|
G |
P2RX7 |
purinergic receptor P2X 7 |
decreases transport increases transport |
EXP |
P2RX7 gene polymorphism results in decreased transport of Ethidium P2RX7 protein results in increased transport of Ethidium |
CTD |
PMID:16263709 |
|
NCBI chr12:121,132,876...121,188,032
Ensembl chr12:121,132,819...121,188,032
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Ethidium inhibits the reaction [cyanoginosin LR results in increased phosphorylation of RELA protein] |
CTD |
PMID:35032610 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SLC22A1 |
solute carrier family 22 member 1 |
multiple interactions affects uptake increases uptake |
EXP ISO |
1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium]; Cimetidine inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium]; Quinine inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium]; Tetraethylammonium inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium] SLC22A1 protein affects the uptake of Ethidium |
CTD |
PMID:19357179 |
|
NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
increases uptake multiple interactions affects uptake |
EXP ISO |
SLC22A2 protein results in increased uptake of Ethidium 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]; Cimetidine inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]; Ethidium inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Quinine inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]; Tetraethylammonium inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium] SLC22A2 protein affects the uptake of Ethidium |
CTD |
PMID:19357179 |
|
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|
G |
SLC22A3 |
solute carrier family 22 member 3 |
increases uptake multiple interactions |
EXP |
SLC22A3 protein results in increased uptake of Ethidium 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium]; Cimetidine inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium]; Quinine inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium]; Tetraethylammonium inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium] |
CTD |
PMID:19357179 |
|
NCBI chr 6:160,348,378...160,452,577
Ensembl chr 6:160,348,378...160,452,577
|
|
G |
STING1 |
stimulator of interferon response cGAMP interactor 1 |
multiple interactions |
ISO |
Ethidium inhibits the reaction [cyanoginosin LR results in increased expression of STING1 protein] |
CTD |
PMID:35032610 |
|
NCBI chr 5:139,475,533...139,482,758
Ensembl chr 5:139,475,533...139,482,935
|
|
G |
TFAM |
transcription factor A, mitochondrial |
increases expression |
EXP |
Ethidium results in increased expression of TFAM mRNA |
CTD |
PMID:22712077 |
|
NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
Ethidium inhibits the reaction [cyanoginosin LR results in increased expression of TNF mRNA] |
CTD |
PMID:35032610 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
affects activity |
EXP |
Ethidium affects the activity of TP53 protein |
CTD |
PMID:35435491 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|